Mundo, Rechel E.
HRN: 21-18-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/14/2022
05/17/2022
IV
500mg
Q8
Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes